HCW Biologics Inc.: 10-Q filed 2021-08-13

Name: HCW Biologics Inc.: 10-Q filed 2021-08-13
Creator: HCW Biologics Inc.

What HCW Biologics Inc. reported in its quarterly report filed 2021-08-13 (fiscal Q2 2021): 23 published measures, 67 facts as tagged in accession 0001193125-21-245367.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-08-13
Fiscal period: fiscal Q2 2021
Accession: 0001193125-21-245367 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HCW Biologics Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-06-30	13,033,394	USD
At 2020-12-31	15,398,086	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-06-30	-23,239,706	USD
At 2021-03-31	-20,025,725	USD
At 2020-12-31	-16,718,397	USD
At 2020-06-30	-15,377,968	USD
At 2020-03-31	-12,331,518	USD
At 2019-12-31	-9,676,294	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2021-06-30	5,050,851	USD
At 2020-12-31	8,455,834	USD
At 2020-06-30	3,168,430	USD
At 2019-12-31	7,355,834	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	-2,750,362	USD	91
2021-01-01 to 2021-06-30	-5,594,358	USD	181
2021-01-01 to 2021-03-31	-2,843,996	USD	90
2020-04-01 to 2020-06-30	-2,778,485	USD	91
2020-01-01 to 2020-06-30	-5,153,999	USD	182
2020-01-01 to 2020-03-31	-2,375,514	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	-2,480,242	USD	181
2020-01-01 to 2020-06-30	-4,144,634	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	23,279	USD	181
2020-01-01 to 2020-06-30	45,076	USD	182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2021-04-01 to 2021-06-30	USD	91
2021-01-01 to 2021-06-30	USD	181
2020-04-01 to 2020-06-30	USD	91
2020-01-01 to 2020-06-30	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	-901,462	USD	181
2020-01-01 to 2020-06-30	2,306	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	-23,279	USD	181
2020-01-01 to 2020-06-30	-45,076	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-06-30	-23,240,202	USD
At 2020-12-31	-16,718,877	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	0	USD	181
2020-01-01 to 2020-12-31	0	USD	366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2021-06-30	1,387,324	USD
At 2020-12-31	1,649,668	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	-2,750,993	USD	91
2021-01-01 to 2021-06-30	-6,163,166	USD	181
2020-04-01 to 2020-06-30	-2,780,007	USD	91
2020-01-01 to 2020-06-30	-5,176,999	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-06-30	10,046,320	USD
At 2020-12-31	12,148,668	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-06-30	4,169,425	USD
At 2020-12-31	1,001,084	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2021-06-30	996,880	USD
At 2020-12-31	155,343	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	2,750,993	USD	91
2021-01-01 to 2021-06-30	6,163,166	USD	181
2020-04-01 to 2020-06-30	2,780,007	USD	91
2020-01-01 to 2020-06-30	5,176,999	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	1,673,163	USD	91
2021-01-01 to 2021-06-30	4,002,976	USD	181
2020-04-01 to 2020-06-30	2,068,783	USD	91
2020-01-01 to 2020-06-30	3,747,207	USD	182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	-3,233,024	USD	91
2021-01-01 to 2021-06-30	-6,554,378	USD	181
2020-04-01 to 2020-06-30	-3,058,271	USD	91
2020-01-01 to 2020-06-30	-5,713,572	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-04-01 to 2021-06-30	1,077,830	USD	91
2021-01-01 to 2021-06-30	2,160,190	USD	181
2020-04-01 to 2020-06-30	711,224	USD	91
2020-01-01 to 2020-06-30	1,429,792	USD	182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	323,897	USD	181
2020-01-01 to 2020-06-30	306,011	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	22,850	USD	181
2020-01-01 to 2020-06-30	2,306	USD	182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-06-30	-2,450,000	USD	181

Inspect the source

Entity: HCW Biologics Inc. / CIK 0001828673
Captured: 2026-09-21T17:29:55.000Z
SEC response SHA-256: ec2f89184d2effc79bd61262508df1bb4955251bd9c779b166cb9345b80a8cfa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001828673.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))